Crossmark Global Holdings, Inc. Merck & Co., Inc. Transaction History

Crossmark Global Holdings, Inc.

$5.23 Billion
Q2 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 189,308 shares of MRK stock, worth $21.5 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

189,308

Previous 183,198 3.34%

Holding current value

$21.5 Million

Previous $24.2 Million 3.05%

% of portfolio

0.45%

Previous 0.46%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$123.8 - $132.96 $756,418 - $812,385	6,110 Added 3.34%	189,308 $23.4 Million
Q1 2024 May 13, 2024	SELL	$113.24 - $131.95 $941,703 - $1.1 Million	-8,316 Reduced 4.34%	183,198 $24.2 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $692,744 - $753,873	6,915 Added 3.75%	191,514 $20.9 Million
Q3 2023 Nov 08, 2023	SELL	$102.95 - $114.33 $2.39 Million - $2.66 Million	-23,249 Reduced 11.19%	184,599 $19.1 Million
Q2 2023 Jul 31, 2023	BUY	$108.61 - $118.38 $1.63 Million - $1.77 Million	14,978 Added 7.77%	207,848 $22.1 Million
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $1.53 Million - $1.71 Million	14,909 Added 8.38%	192,870 $20.5 Million
Q4 2022 Jan 19, 2023	SELL	$87.44 - $112.11 $3.08 Million - $3.94 Million	-35,169 Reduced 16.5%	177,961 $19.7 Million
Q3 2022 Nov 01, 2022	BUY	$84.53 - $94.96 $1.52 Million - $1.7 Million	17,927 Added 9.18%	213,130 $18.4 Million
Q2 2022 Jul 29, 2022	BUY	$83.49 - $94.64 $2 Million - $2.27 Million	24,002 Added 14.02%	195,203 $17.8 Million
Q1 2022 May 11, 2022	SELL	$73.51 - $82.4 $851,760 - $954,768	-11,587 Reduced 6.34%	171,201 $14 Million
Q4 2021 Jan 10, 2022	BUY	$72.28 - $90.54 $181,278 - $227,074	2,508 Added 1.39%	182,788 $14 Million
Q3 2021 Oct 21, 2021	BUY	$71.68 - $78.83 $12 Million - $13.2 Million	167,508 Added 1311.53%	180,280 $13.5 Million
Q3 2021 Oct 13, 2021	SELL	$71.68 - $78.83 $12.1 Million - $13.3 Million	-168,586 Reduced 92.96%	12,772 $576,000
Q2 2021 Jul 21, 2021	BUY	$70.31 - $77.77 $8.89 Million - $9.83 Million	126,374 Added 229.84%	181,358 $14.1 Million
Q1 2021 Apr 15, 2021	BUY	$68.86 - $81.11 $279,158 - $328,819	4,054 Added 7.96%	54,984 $4.24 Million
Q4 2020 Jan 14, 2021	SELL	$71.77 - $79.65 $95,167 - $105,615	-1,326 Reduced 2.54%	50,930 $4.17 Million
Q3 2020 Oct 08, 2020	SELL	$73.18 - $82.95 $94,621 - $107,254	-1,293 Reduced 2.41%	52,256 $4.34 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $87,109 - $99,120	1,237 Added 2.36%	53,549 $4.14 Million
Q1 2020 Apr 28, 2020	SELL	$63.36 - $87.82 $66,654 - $92,386	-1,052 Reduced 1.97%	52,312 $3.84 Million
Q4 2019 Feb 06, 2020	BUY	$77.58 - $87.54 $43,755 - $49,372	564 Added 1.07%	53,364 $4.85 Million
Q3 2019 Oct 09, 2019	SELL	$76.08 - $82.93 $874,083 - $952,782	-11,489 Reduced 17.87%	52,800 $4.45 Million
Q2 2019 Jul 09, 2019	BUY	$69.84 - $81.59 $48,049 - $56,133	688 Added 1.08%	64,289 $5.39 Million
Q1 2019 May 02, 2019	SELL	$69.58 - $79.36 $137,350 - $156,656	-1,974 Reduced 3.01%	63,601 $5.29 Million
Q4 2018 Jan 31, 2019	BUY	$65.24 - $75.71 $122,585 - $142,259	1,879 Added 2.95%	65,575 $5.01 Million
Q3 2018 Nov 08, 2018	BUY	$57.69 - $67.84 $284,988 - $335,129	4,940 Added 8.41%	63,696 $4.52 Million
Q2 2018 Jul 31, 2018	SELL	$50.83 - $59.72 $608,943 - $715,445	-11,980 Reduced 16.94%	58,756 $3.57 Million
Q1 2018 Apr 16, 2018	SELL	$50.96 - $59.23 $128,062 - $148,844	-2,513 Reduced 3.43%	70,736 $3.85 Million
Q4 2017 Feb 05, 2018	SELL	$51.62 - $61.64 $27,823 - $33,223	-539 Reduced 0.73%	73,249 $4.12 Million
Q3 2016 Oct 25, 2017	BUY	N/A	73,788	73,788 $4.73 Million

Others Institutions Holding MRK

# of Institutions

3,830

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Merck & Co., Inc. Transaction History